Congress

Human embryo under microscope
Health

U.S. researcher says he’s ready to start four pregnancies with ‘three-parent’ embryos

By Emily Mullin

Nancy Pelosi, Wendell Primus
Politics

The health policy experts shaping Nancy Pelosi’s approach to drug pricing

By Lev Facher

Pharmalot

Pharmalittle: J&J gets U.S. nod for first targeted bladder cancer drug; Allergan wins key support from advisory firms

By Ed Silverman

Nancy Pelosi & Lloyd Doggett
Politics

Democrats feud over drug pricing policy, as progressives push pragmatists to be bolder

By Lev Facher and Nicholas Florko

Chuck Grassley, Ron Wyden
Pharmalot

Lawmakers ask the Trump administration to investigate PBM pricing practices

By Ed Silverman

The Maryland State Capitol Building
Politics

Pharma lobbyists flooded Maryland to block a drug-pricing bill. Opponents pushed back — and won

By Lev Facher

Anna Eshoo, Jan Schakowsky
Politics

‘I don’t know how you people sleep at night’: Visibly irate lawmakers blast pharma, PBMs over insulin prices

By Nicholas Florko

Diabetes insulin injection
Pharmalot

As congressional hearing looms, Sanofi cuts insulin prices for some patients

By Ed Silverman

Alex Azar at STAT
Politics

‘He calls me, I call him’: Alex Azar on his relationship with President Trump, drug pricing, and winning over skeptical conservatives

By Lev Facher

Chuck Grassley (R-IA) walks to a vote
Politics

PBMs sidestep the Senate’s tough questions — but lawmakers hint at legislation

By Nicholas Florko

Senate Hearing
Politics

Today, five pharmacy ‘middlemen’ head to Capitol Hill’s hot seat. Here’s what you need to know

By Nicholas Florko

Pharmalot

Pharmalittle: Oklahoma trims claims against J&J and Teva in opioid suit; House committee poised to vote on drug pricing bills

By Ed Silverman

Richard Neal
Politics

Powerful House committee to weigh legislation aimed at shedding more light on high drug prices

By Nicholas Florko

Crushed Aluminum Can on side of road
First Opinion

Sen. Grassley: Stop kicking Medicaid’s safety net hospital payments down the road

By Chuck Grassley

Insulin factory - Novo
Health

Faced with rising anger on drug prices, Cigna plans to reduce insulin costs to $25 a month for many patients

By Matthew Herper

FDA; Drug Administration campus
Pharmalot

Drug makers continue to clamor for FDA approval of orphan drugs

By Ed Silverman

CRISPR for congress
Politics

The mark of a job well done for a CRISPR lobbyist? Silence in Congress

By Nicholas Florko

Donald Trump - improving free inquiry, transparency, and accountability
Politics

Will Trump’s new free speech order affect research funding?

By Lev Facher

Rep. Elijah Cummings
Politics

House Democrats request Purdue opioid documents, focusing on the role of the Sacklers

By Andrew Joseph

Antibiotic Resistance
Pharmalot

Efforts to import drugs from Canada advance at state level, with Florida latest to get in line

By Ed Silverman

Norman E. Sharpless
Politics

A believer in biotech and big data: How Ned Sharpless vaulted to the top of the FDA

By Lev Facher and Kate Sheridan

Ron Wyden
Pharmalot

Wyden probes a patient advocacy group over its ties to opioid makers

By Ed Silverman

Sen. Chuck Grassley (R-IA)
Politics

Key senators call five pharmacy middlemen to testify about drug prices

By Nicholas Florko

Suboxone
First Opinion

Deregulating buprenophine prescribing for opioid use disorder will save lives

By Kevin Fiscella and Sarah E. Wakeman

Donald Trump speaks prior to signing bills intended to lower prescription drug prices
Politics

Trump budget pitches capping seniors’ out-of-pocket drug costs, cutting NIH funding

By Lev Facher

Fenway Park
Politics

How do you improve Medicare? Maybe you watch Major League Baseball

By Nicholas Florko

Title Devin Nunes
Politics

GOP lawmakers lambaste Democratic push to strip patents from drug companies

By Lev Facher

Pharmalot

Pharmalittle: Allergan depression drug fails three trials; Vertex CEO appears before Parliament

By Ed Silverman

Hugh Hewitt
Politics

The $100,000 dark-money mystery group behind a pharma-bashing Facebook campaign

By Ike Swetlitz

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy